Organon Pharma Indonesia Tbk. vs Selamat Sempurna Tbk — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Selamat Sempurna Tbk trades at Rp1,735 (market cap 10.14T, 3.24M 24h volume). The key difference: Selamat Sempurna Tbk is far larger — about 97.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SMSM | |
|---|---|---|
Market Cap | 104.4B | 10.14T |
Volume | — | 3.24M |
Lot | — | 32.38K |
Turnover | — | 5.64B |
Average Price | — | 1,741.64 |
Value | — | 5.64B |
Indicative Equilibrium Price | — | 1,735 |
Indicative Equilibrium Volume | — | 47 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Selamat Sempurna Tbk (the Company) was established in Indonesia based on Notarial Deed No. 207 of Ridwan Suselo, S.H., dated January 19, 1976.
Read more on SMSM →